It was concluded that a GnRH antagonist protocol is better than a long agonist protocol to reduce the rate of severe OHSS, and there was no difference in ongoing pregnancy, live birth rate, and other indicators between the two protocols [9, 10]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.